# Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Formulations of ABT-450

> **NCT01091649** · PHASE1 · COMPLETED · sponsor: **Abbott** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ABT-450
- **DRUG:** ritonavir
- **DRUG:** ABT-450

## Key facts

- **NCT ID:** NCT01091649
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01091649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01091649, "Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Formulations of ABT-450". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01091649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*